Cargando…
Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection
Hepatitis C virus (HCV) infection affects as many as 185 million people globally, many of whom are chronically infected and progress over time to cirrhosis, decompensated liver disease, hepatocellular carcinoma, and eventually death without a liver transplant. In the United States, HCV genotype 1 co...
Autores principales: | FakhriRavari, Alireza, Malakouti, Mazyar, Brady, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913075/ https://www.ncbi.nlm.nih.gov/pubmed/27350940 http://dx.doi.org/10.14218/JCTH.2016.00007 |
Ejemplares similares
-
608. Evaluation of Safety of High-Dose Beta-Lactam Antibiotics in Patients with End-Stage Kidney Disease: A Retrospective Cohort Study
por: Varona, Jerald, et al.
Publicado: (2022) -
Systemic corticosteroids for management of COVID-19: Saving lives or causing harm?
por: FakhriRavari, Alireza, et al.
Publicado: (2021) -
Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy
por: FakhriRavari, Alireza, et al.
Publicado: (2022) -
Interferon-free treatments in patients with hepatitis C genotype 3 infection in a tertiary hospital
por: del Rio-Valencia, Juan Carlos, et al.
Publicado: (2018) -
The New Era of Interferon-Free Treatment of Chronic Hepatitis C
por: Solbach, Philipp, et al.
Publicado: (2015)